Seeking Alpha
28 Sept 2026, 20:43 UTC · 1h ago
Verdict
Headline takes no side. We score ZYME +0.60 — strongly bullish.
+0.60strongly bullish
More positive than 77% of ticker scores this week
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
More positive than 95% of relationship scores this week
[a_to_b] Zymeworks Inc. has acquired Theravance Biopharma.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
1h ago
—
ZYME hasn't traded since this ran. Last close $27.12 (Sep 28); the reaction starts at the next open.
ZYME chart →
